Literature DB >> 33999752

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.

Eva Tiensuu Janson1, Ulrich Knigge2, Gitte Dam3, Birgitte Federspiel4, Henning Grønbaek3, Peter Stålberg5, Seppo W Langer6,7, Andreas Kjaer8,9, Johanna Arola10, Camilla Schalin-Jäntti11, Anders Sundin12, Staffan Welin1, Espen Thiis-Evensen13, Halfdan Sorbye14,15.   

Abstract

BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic. AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

Entities:  

Keywords:  ;; Diagnosis; neuroendocrine carcinoma; neuroendocrine tumour; treatment

Mesh：

Year:  2021        PMID： 33999752     DOI： 10.1080/0284186X.2021.1921262

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


  6 in total

1.  A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms.

Authors:  Esben Andreas Carlsen; Kristian Lindholm; Andreas Kjaer; Flemming Littrup Andersen; Amalie Hindsholm; Mathias Gæde; Claes Nøhr Ladefoged; Mathias Loft; Camilla Bardram Johnbeck; Seppo Wang Langer; Peter Oturai; Ulrich Knigge
Journal:  EJNMMI Res       Date:  2022-05-28       Impact factor: 3.434

Review 2.  Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs).

Authors:  Krzysztof Kaliszewski; Maksymilian Ludwig; Maria Greniuk; Agnieszka Mikuła; Karol Zagórski; Jerzy Rudnicki
Journal:  Cancers (Basel)       Date:  2022-04-17       Impact factor: 6.575

Review 3.  Role of Somatostatin Signalling in Neuroendocrine Tumours.

Authors:  Olesja Rogoza; Kaspars Megnis; Marija Kudrjavceva; Aija Gerina-Berzina; Vita Rovite
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

Review 4.  Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum.

Authors:  Alessandro Ottaiano; Mariachiara Santorsola; Francesco Perri; Ugo Pace; Bruno Marra; Marco Correra; Francesco Sabbatino; Marco Cascella; Nadia Petrillo; Monica Ianniello; Marika Casillo; Gabriella Misso; Paolo Delrio; Michele Caraglia; Guglielmo Nasti
Journal:  Biology (Basel)       Date:  2022-02-08

Review 5.  An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Jiayun M Fang; Jay Li; Jiaqi Shi
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.374

6.  Volumetric parameters from [18 F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Henning Langen Stokmo; Mahmoud Aly; Inger Marie Bowitz Lothe; Austin J Borja; Siavash Mehdizadeh Seraj; Rina Ghorpade; Xuan Miao; Geir Olav Hjortland; Eirik Malinen; Halfdan Sorbye; Thomas J Werner; Abass Alavi; Mona-Elisabeth Revheim
Journal:  J Neuroendocrinol       Date:  2022-06-21       Impact factor: 3.870
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.